Why the study?
The relationship between depressive symptoms and ischemic heart disease in postmenopausal women had not been previously reported.
Are depressive symptoms associated with an increased prevalence of ischemic heart disease in postmenopausal women?
Are depressive symptoms associated with an increased prevalence of ischemic heart disease in postmenopausal women?
Depressive symptoms are associated with a nearly twofold increased odds of ischemic heart disease among postmenopausal women, highlighting a potential target for cardiovascular risk reduction.
Depressive symptoms were associated with higher IHD prevalence in postmenopausal women; hypothesis-generating and should not yet change practice.
Background: The negative impact of depression on cardiovascular health has drawn much attention. However, the relationship between depressive symptoms and ischemic heart disease (IHD) in postmenopausal women has not been previously reported. Methods: This cross-sectional study analyzed data from the National Health and Nutrition Examination Survey (NHANES) spanning 2005 to 2018, including 6,538 postmenopausal women. Weighted multivariable logistic regression analyses were conducted to examine the independent association between depressive symptoms and IHD. Results: The fully adjusted model revealed a significant association between depressive symptoms and IHD (OR 1.97, 95% CI [1.24, 3.13]). Subgroup and interaction analyses revealed that depressive symptoms were more strongly linked to IHD risk among younger women, those with lower annual household incomes, non-Hispanic Black women, and individuals with comorbidities such as diabetes and hypercholesterolemia. Moreover, the presence of hypertension moderated the relationship between depressive symptoms and IHD. Conclusion: Our findings indicate a significant association between depressive symptoms and increased IHD prevalence among postmenopausal women in the United States, with hypertension acting as a moderating factor. These results offer new insights and potential targets for improving cardiovascular health in this population.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: